EphA4 Protein, Rhesus Macaque (HEK293, His)
Based on 1 Customer Validation
The EphA4 protein is a receptor tyrosine kinase that participates in contact-dependent bidirectional signaling with ephrin A and ephrin B ligands. EphA4 is activated by GPI-anchored EFNA and transmembrane EFNB and regulates cell morphology, integrin-dependent adhesion, and GTPase activity. EphA4 Protein, Rhesus Macaque (HEK293, His) is the recombinant Rhesus Macaque-derived EphA4 protein, expressed by HEK293 , with C-His labeled tag.
- Species: Rhesus Macaque
- Source: HEK293
-
Storage:Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.
Biological Activity
Description
The EphA4 protein is a receptor tyrosine kinase that participates in contact-dependent bidirectional signaling with ephrin A and ephrin B ligands. EphA4 is activated by GPI-anchored EFNA and transmembrane EFNB and regulates cell morphology, integrin-dependent adhesion, and GTPase activity. EphA4 Protein, Rhesus Macaque (HEK293, His) is the recombinant Rhesus Macaque-derived EphA4 protein, expressed by HEK293 , with C-His labeled tag.
Background
The EphA4 protein, a receptor tyrosine kinase, engages in contact-dependent bidirectional signaling with membrane-bound ephrin family ligands on adjacent cells. Distinguished by its high promiscuity, EphA4 uniquely binds and is physiologically activated by both GPI-anchored ephrin-A and transmembrane ephrin-B ligands, including EFNA1 and EFNB3. Upon activation by ephrin ligands, EphA4 modulates cell morphology and integrin-dependent cell adhesion through the regulation of Rac, Rap, and Rho GTPases activity. Crucial in the development of the nervous system, EphA4 controls various steps of axonal guidance, including the establishment of corticospinal projections and the segregation of motor and sensory axons during neuromuscular circuit development. In synaptic plasticity, EphA4 participates by phosphorylating CDK5 at 'Tyr-15,' leading to the regulation of RHOA and dendritic spine morphogenesis. Furthermore, EphA4 plays roles in repair after injury by preventing axonal regeneration and in angiogenesis, contributing to central nervous system vascular formation. Its promiscuity extends its involvement in various cell-cell signaling processes, regulating the development of the thymic epithelium and, during the development of the cochlear organ of Corti, facilitating pillar cell separation through the formation of a ternary complex with ADAM10 and CADH1, leading to the cleavage of CADH1 and disruption of adherens junctions. EphA4 also phosphorylates CAPRIN1, promoting CAPRIN1-dependent formation of a membraneless compartment.
Verified Bioactivity
1.This product does not contain protein kinase domain.
2.Measured by its binding ability in a functional ELISA. Immobilized Rhesus Macaque EphA4 at 10 μg/mL (100 μL/well) can bind Rhesus Macaque EFNA5. The ED50 for this effect is 29.19 ng/mL.
MCE Validation Data
-
Purity - SDS-PAGE
Purity - SDS-PAGE
-
Bioactivity - ELISA
Bioactivity - ELISA
Technical Parameters
-
Species Rhesus Macaque
-
Source HEK293
-
Tag C-His
-
Accession
G7N911 (V20-T547)
-
Molecular Construction
-
N-term
-
EphA4 (V20-T547)
Accession # G7N911 -
His
-
C-term
-
-
Protein Length
Partial
-
Synonyms
EPHA4; EK8; Prev. TYRO1; Receptor Protein-Tyrosine Kinase HEK8; Hek8; Receptor Protein-Tyrosine Kinase; Tyrosine-Protein Kinase Receptor SEK; TYRO1 Protein Tyrosine Kinase; Tyrosine-Protein Kinase TYRO1; EphA4; Ephrin Type-A Receptor 4; HEK8; EPH-Like Kin
-
AA Sequence
VTGSRVYPANEVTLLDSRSVQGELGWIASPLEGGWEEVSIMDEKNTPIRTYQVCNVMEPSQNNWLRTDWITREGAQRVYIEIKFTLRDCNSLPGVMGTCKETFNLYYYESDNDKERFIRENQFVKIDTIAADESFTQVDIGDRIMKLNTEIRDVGPLSKKGFYLAFQDVGACIALVSVRVFYKKCPLTVRNLAQFPDTITGADTSSLVEVRGSCVNNSEEKDVPKMYCGADGEWLVPIGNCLCNAGHEERSGECQACKIGYYKALSTDATCAKCPPHSYSVWEGATSCTCDRGFFRADNDAASMPCTRPPSAPLNLISNVNETSVNLEWSSPQNTGGRQDISYNVVCKKCGAGDPSKCRPCGSGVHYTPQQNGLKTTKVSITDLLAHTNYTFEIWAVNGVSKYNPSPDQSVSVTVTTNQAAPSSIALVQAKEVTRYSVALAWLEPDRPNGVILEYEVKYYEKDQNERSYRIVRTAARNTDIKGLNPLTSYVFHVRARTAAGYGDFSEPLEVTTNTVPSRIIGDGANST
-
Molecular Weight
Approximately 59.8-80 kDa.
-
Purity
≥ 95%, as determined by reducing SDS-PAGE.
Product Properties
Lyophilized powder.
Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4.
<1 EU/μg, determined by LAL method.
It is not recommended to reconstitute to a concentration less than 100 μg/mL in ddH2O. For long term storage it is recommended to add a carrier protein (0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose).
Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.
Room temperature in continental US; may vary elsewhere.
Documentation
-
Data Sheet (239 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)